Amgen Cholesterol IP Suit Restarts As EPO Decision Looms
A London judge on Thursday lifted a stay on Amgen's suit to block a cholesterol drug from Sanofi-Aventis and Regeneron, releasing the defendants from an agreement to be bound by an...To view the full article, register now.
Already a subscriber? Click here to view full article